相关实验视频

Updated: Jan 8, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

塑造质母细胞瘤微环境以增强CAR-NK免疫疗法

Emily Tang¹, Jake Y Chen²

¹North Carolina School of Science and Mathematics, Durham, NC, United States.

Frontiers in immunology

|December 17, 2025

概括

CAR-NK细胞疗法对血液癌症有希望,但由于其免疫抑制瘤微环境,它与质母细胞瘤作斗争. 克服这些障碍是提高CAR-NK对固体瘤的疗效的关键.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

化学抗原受体-自然杀手 (CAR-NK) 细胞疗法对血液癌症有效.
由于免疫抑制性瘤微环境,在像质母细胞瘤这样的固体瘤中有效性有限.
质母细胞瘤使用多种策略来逃避免疫.

研究的目的:

审查由质母细胞瘤微环境使用的免疫抑制机制.
讨论克服CAR-NK疗法的这些抑制作用的新兴策略.

主要方法:

关于质母细胞瘤免疫抑制的当前文献的综述.
分析增强CAR-NK细胞治疗疗效的策略.
专注于基因工程和组合疗法.

主要成果:

质母细胞瘤利用 stromal 屏障,缺氧,免疫抑制性细胞因子,连接体下调和免疫检查点上调用于免疫逃避.
新兴的策略包括基因工程NK细胞和向瘤层与瘤病毒.

结论:

针对质母细胞瘤的免疫抑制微环境对于有效的CAR-NK疗法至关重要.
对于个性化质母细胞瘤治疗,需要结合方法和先进的奥米学研究.

关键词:

仿制性抗原受体的复制性受体.质母细胞瘤质母细胞瘤免疫疗法免疫疗法微环境是一个微环境.自然杀手细胞是什么?

更多相关视频

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.